Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RFNG |
| Upstream (Parents) |
|---|
| (<<) BTD → RFNG |
| (<<) SHROOM2 → RFNG |
| (<<) SIGIRR → RFNG |
| (<<) TTC23 → RFNG |
| Downstream (Children) |
|---|
| RFNG → AQP4 (>>) |
| RFNG → GPR22 (>>) |
| RFNG → LOC92973 (>>) |
| RFNG → FBXO21 (>>) |
| RFNG → CDC14B (>>) |
| RFNG → ACAN (>>) |
| RFNG → CASKIN2 (>>) |
| RFNG → PRB2///PRB1 (>>) |
| RFNG → PGAP3 (>>) |
| RFNG → CPT1A (>>) |
| RFNG → HHLA3 (>>) |
| RFNG → MYL5 (>>) |
| RFNG → VAMP2 (>>) |
| RFNG → SMAD4 (>>) |
| RFNG → LOC440248///HERC2P2///HERC2P3 (>>) |
| RFNG → SHROOM2 (>>) |
| RFNG → SIGIRR (>>) |
| RFNG → NPPA (>>) |
| RFNG → ATP5D (>>) |
| RFNG → TP53TG1 (>>) |
| RFNG → TTC23 (>>) |
| RFNG → ABCD4 (>>) |
